Xenetic Biosciences Inc.

(XBIO) Trade

By |

Profile

Xenetic Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics. The company's lead investigational product candidate is oncology therapeutic XBIO-101 (sodium cridanimod) for the treatment of progesterone resistant endometrial cancer. Further, company's proprietary drug development platform, PolyXen, enables next-generation biologic drugs by improving their half-life and other pharmacological properties. The company has ongoing business development activities to explore partnerships utilizing its PolyXen delivery platform.

Contact Information

Website: www.xeneticbio.com
Email: jtc@jenenethomascommunications.com
Main Phone: +1 781 778-7720
Address: 99 Hayden Avenue
Address 2: Suite 230
State: MA
City / Town: Lexington
Country: USA
Postal Code: 02421

Issuer Information

Exchange: NSC
CEO: Jeffrey F. Eisenberg
Employees: 5
NAICS: Medicinal and Botanical Manufacturing(325411)
$ 2.42 $ 0. (0.00%)
Last Price 2.42 Change $ 0. Change % 0.00 Tick N/A
Bid 2.42 Bid Size 1,000.00 Ask 2.57 Ask Size 200.00
Open 2.42 High 2.42 Low 2.42 Prev Close 2.42
Last Trade Volume 337 52 Wk Hi 8.95 52 Wk Low 1.37
Market Cap 22.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 9,403,889.00 EPS (TTM) -0.11 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 10 10 10 10
Mean Target Price Estimate 10 10 10 10
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/30/17 08/30/17 08/30/17 08/30/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1